Craniosacral Therapy for Autism and ADHD

How craniosacral therapy helps

What a CST session looks like for an autistic or ADHD client: a well-adapted CST session for an autistic or ADHD adult or child is profoundly gentle, clothing-on, and uses no more pressure than the weight of a small coin on the skin — typically around 5 grams. The practitioner does not 'crack', manipulate, or apply any sudden force. The session is built around sustained, listening contact at the cranium (particularly the temporal bones and the base of the skull, an area that many autistic and ADHD clients carry long-standing tension), along the spine, at the sacrum, at the diaphragm and around the lower ribs, and — gently and externally only — at the abdomen, neck, jaw, and the soft tissues around the vagus-nerve exit at the base of the skull. Sessions typically last 45 to 60 minutes for adults and shorter for children, with the first session usually a longer conversation about sensory needs, communication preferences, and what the client is hoping to get out of the work.

Session design is the key difference for many autistic and ADHD clients. A good practitioner working with neurodivergent clients will explicitly ask about sensory preferences before the session — lighting levels (low or natural; fluorescent flicker is a common trigger), ambient sound (white noise, quiet, or specific music), temperature of the room, predictability of the environment (a consistent room, a familiar room layout, a quiet waiting area), whether the client prefers to be spoken to or have silence, whether they prefer to lie on their back, side, or stay seated, and whether they want to know what the practitioner is going to do before each contact or prefer not to. Many autistic and ADHD clients find the experience of being able to stop, redirect, or leave at any time a meaningful part of what makes the work possible. Parents of autistic or ADHD children should expect a practitioner to want a full pre-session conversation about the child's specific profile, communication style, sensory triggers, and any co-occurring conditions (seizure history, tics, self-regulation patterns, meltdowns), and to be flexible about session duration, breaks, and even whether the session happens in the treatment room or a different space.

Where CST can be helpful for co-occurring symptoms: many autistic and ADHD adults and children describe a persistent state of heightened autonomic arousal — sometimes called 'always-on', 'wired-but-tired', or 'shutdown-after-mask' — that can be exhausting to manage. CST is not a treatment for the underlying neurodevelopmental profile, but many clients report that the very-light, sustained contact in a well-adapted session can support parasympathetic-leaning autonomic regulation: easier settling, better sleep on the night of a session, less somatic-tension load, a felt sense of permission to rest. The Jäkel & von Hauenschild 2019 systematic review of CST notes that the strongest evidence signals are in pain, sleep, and autonomic regulation — areas that overlap with several co-occurring symptoms of ASD and ADHD, while the core diagnostic features (social communication differences for autism, inattention and impulsivity for ADHD) are not the right target for bodywork. Practical ways families report using CST alongside the established plan: a sensory-friendly session booked on a lower-demand day for a child whose school week has been heavy; a session for an ADHD adult whose sleep has been disrupted; a session for an autistic client in burnout from masking; a series of sessions during a planned transition (school change, new job, post-crisis).

How it usually combines with the rest of the autism and ADHD care plan: CST for ASD and ADHD is almost always used alongside, not instead of, the established care plan. The pillars of that plan are: a diagnostic assessment (paediatrician, child and adolescent psychiatrist, clinical psychologist, or a neurodevelopmental specialist depending on age and country); psychoeducation and connection with an autistic or ADHD community and advocacy network (in the UK: the National Autistic Society, ADHD UK; in the US: Autism Society of America, CHADD; in Italy: ANGSA, AIFA on medication access; in Germany: autismus Deutschland, ADHS Deutschland); school accommodations (an Individual Education Plan in the US, an Education, Health and Care Plan in England, a Piano Didattico Personalizzato in Italy, or a Nachteilsausgleich / sonderpädagogische Förderung in Germany); for ADHD, a thoughtful conversation about medication where appropriate — methylphenidate, lisdexamfetamine, atomoxetine, and guanfacine have a strong evidence base in both children and adults; occupational therapy for sensory differences; speech and language therapy for social-communication differences; and CBT or other evidence-based approaches for co-occurring anxiety or depression. A practitioner who positions CST as a primary treatment for ASD or ADHD, or who suggests it before the diagnostic assessment, or who suggests it can replace medication, school accommodations, or therapies that work on the core features, is not the right fit. Sessions are typically shorter for children (20 to 40 minutes of hands-on work), longer for adults (45 to 60 minutes), and many clients and practitioners settle into an initial course of 4 to 8 sessions over 4 to 8 weeks with a clear reassessment conversation at that point.

What the evidence says

There are no large-scale RCTs specifically examining CST for ASD or ADHD. One small pilot study (2015, n=15) examined CST for children with ASD and found improvements in sensory processing and emotional functioning. A 2016 qualitative study of CST for ADHD noted subjective improvements in attention and behavior reported by parents. The evidence base is too limited to draw firm conclusions, and CST should not be presented as a treatment for the core symptoms of ASD or ADHD.

Studies and reviews worth knowing for autism, ADHD and CST:

- DSM-5-TR (American Psychiatric Association, 2022) — the current diagnostic standard for ASD and ADHD in US clinical practice. Confirms both as neurodevelopmental disorders with distinct diagnostic criteria (social communication + restricted/repetitive behaviours for ASD; inattention and/or hyperactivity-impulsivity for ADHD). The DSM-5-TR is explicit that these are not behaviours that can be 'cured' by any form of bodywork or training. - ICD-11 (WHO, 2022) — international classification. ASD ICD-11 6A02 (autism spectrum disorder); ADHD ICD-11 6A04 (attention deficit hyperactivity disorder). Both are recognised as neurodevelopmental disorders with established diagnostic criteria and substantial impact on function. - NICE CG170 (UK, 2014, last updated 2021) — Autism spectrum disorder in under 19s: support and management. First-line: psychoeducation, parent-mediated support, social-communication interventions (e.g. naturalistic developmental behavioural interventions), school accommodations, and focused support for co-occurring conditions. Does not recommend CST or any form of bodywork as a treatment for the core features of ASD. - NICE NG87 (UK, 2018, last updated 2024) — Attention deficit hyperactivity disorder: diagnosis and management. First-line: psychoeducation, school accommodations, parent-training programmes, cognitive approaches for adults, medication (methylphenidate, lisdexamfetamine, atomoxetine, or guanfacine) where appropriate. Does not recommend CST or any form of bodywork as a treatment for the core features of ADHD. - Hyman SL, Levy SE, Myers SM, et al. (American Academy of Pediatrics, 2020) — Clinical Report: Identification, Evaluation, and Management of Children With Autism Spectrum Disorder. Recommends early identification, comprehensive developmental and medical evaluation, and evidence-based interventions focused on social communication, adaptive skills, and co-occurring conditions. Explicitly does not recommend CST as a treatment for ASD. - Wolraich ML, Hagan JF, Allan C, et al. (American Academy of Pediatrics, 2019) — Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents. Recommends a multimodal approach including parent-training, school accommodations, behavioural interventions, and medication where appropriate. Explicitly does not recommend CST as a treatment for ADHD. - Green VA, Pituch KA, Itchon J, Choi A, O'Reilly M, Sigafoos J. (2006) — Internet survey of parents' use of complementary and alternative therapies for children with autism. Reported that a meaningful minority of parents of autistic children describe subjective improvement after CST and related sensory-integration approaches, but the study was observational and did not demonstrate that the changes were due to the therapies. Useful as a baseline of who is seeking this care, not as a basis for treatment decisions. - Escalona A, Field T, Singer-Strunck R, Cullen C, Hartshorn K. (2001) — Brief report: improvements in the behaviour of children with autism following massage therapy. A small pilot study in which 20 children with autism received massage therapy over a 5-month period and showed reduced stereotyped behaviour and improved social relatedness on parent-completed rating scales. This is small, open-label, and not an RCT; it is not the basis on which to make treatment decisions. It is the closest the published literature comes to a CST-adjacent controlled study in autism. - Haller H, Lauche R, Sundberg T, Dobos G, Cramer H. (2019, updated 2022) — Craniosacral therapy for chronic pain: a systematic review and meta-analysis of randomised controlled trials. Found moderate-quality evidence that CST reduces pain and improves function in selected adult chronic-pain populations. Does not include ASD or ADHD populations. - Jäkel R, von Hauenschild P. (2019) — Therapeutic effects of craniosacral therapy: a systematic review. Concluded that the overall evidence base for CST is limited, with the strongest signals in chronic pain, sleep, and autonomic regulation. Does not include ASD or ADHD populations and is explicit that further rigorous RCTs are needed across all indications.

Honest-limit paragraph: there is currently no published randomised controlled trial of craniosacral therapy specifically for autism spectrum disorder or ADHD. The few published studies in this space (Escalona 2001, Green 2006) are small, observational or pilot, and not the basis on which to make treatment decisions. The strongest evidence base for ASD and ADHD is concentrated in the first-line interventions named in NICE CG170, NICE NG87, AAP Hyman 2020, and AAP Wolraich 2019 — none of which recommend CST. The argument for trying CST for co-occurring symptoms (sleep, anxiety, sensory overload, autonomic dysregulation) is therefore indirect and practical — some autistic and ADHD adults and children report subjective benefit, and the autonomic-down-regulation work is consistent with what the broader CST literature shows is the most plausible mechanism — and it should always be weighed against the standard advice to keep the established care plan (diagnostic assessment, school accommodations, occupational therapy, speech and language therapy, parent-mediated support, medication where appropriate) as the foundation, and to use complementary bodywork as an adjunct, not a substitute.

What to expect

Sessions for neurodivergent individuals are typically adapted to the person's sensory needs and communication style. Sessions are usually 45 minutes. The touch is extremely light and the environment is calm. Many practitioners are experienced in working with neurodivergent clients and will adapt their approach to your child's or your specific needs. Some people with ASD or ADHD find the experience grounding and calming.

Practical next steps if you are considering CST for ASD or ADHD:

1. Diagnostic assessment and care plan first. If you or your child do not yet have a confirmed ASD or ADHD diagnosis, start with the diagnostic assessment through a paediatrician, child and adolescent psychiatrist, clinical psychologist, or adult neurodevelopmental specialist. CST is not a diagnostic tool and cannot confirm or rule out ASD or ADHD. If a diagnosis is already in place, confirm with your clinician that the proposed CST work is reasonable for a specific co-occurring symptom (sleep, anxiety, sensory overload, somatic tension) rather than the diagnosis itself. 2. Lock in the established care plan before adding CST. This means, for ASD: psychoeducation, parent-mediated support where appropriate, school accommodations (an Individual Education Plan in the US, an EHCP in England, a PDP in Italy, or Nachteilsausgleich in Germany), occupational therapy for sensory differences, speech and language therapy for social-communication differences, and focused support for any co-occurring anxiety or sleep difficulties. For ADHD: psychoeducation, school accommodations, parent-training programmes, cognitive approaches for adults, and a thoughtful conversation with your clinician about medication where appropriate. If you or your child is not yet connected with any of these supports, the right next step is usually to set them up first, then add CST as an adjunct. 3. Choose a practitioner who works within the medical plan and respects neurodivergent communication. Look for: formal CST training (typically a diploma from a recognised CST school), specific experience or post-registration training with neurodivergent clients (children and/or adults), explicit willingness to have a pre-session conversation about sensory needs and communication preferences, openness to involving a parent or partner in the session if the client wants, a clear no-pressure, no-consent-without-pause consent process, and explicit willingness to refer back to your medical team if anything is unclear. A practitioner who pressures you to skip the diagnostic assessment, who promises that CST can cure ASD or ADHD, who suggests replacing medication or school accommodations, or who dismisses the importance of occupational therapy and speech and language therapy is not the right fit. 4. Keep CST as an adjunct, not a substitute. Plan an initial course of 4 to 8 sessions over 4 to 8 weeks with a clear reassessment conversation at the end. The point is to see whether your specific situation — or your child's specific situation — shows measurable change in one or more co-occurring symptoms (sleep hours, anxiety days, sensory-meltown frequency, somatic-tension load, school-day functioning). Track these specific things rather than overall impression. If there is no clear change by the end of the initial course, the diagnosis and the plan need revisiting with your clinical team, not more sessions. 5. Escalate or stop if anything changes. Specific signs that warrant stopping CST and going back to your clinical team include: any new red-flag symptom (see the safety block in the intro); a marked increase in distress, sensory overload, or shutdown after the session rather than a settling response; any new or worsening self-harm, suicidal ideation, or statements about wanting to die; new or worsening restrictive eating or rapid weight loss; new or worsening tics; a marked regression in sleep, mood, or self-regulation that does not recover with routine adjustments; a parental or partner sense that something is wrong; or a practitioner response that feels dismissive of medical questions or neurodivergent communication preferences. Most well-trained CST practitioners working with neurodivergent clients welcome this conversation — a good practitioner would rather you go back to your clinical team than push for more sessions when something has changed. There is no evidence that CST can cure or treat ASD or ADHD, and a good practitioner will not pretend otherwise.